¹⁸F-FDG PET/CT role in Pott disease

Rev Esp Med Nucl Imagen Mol (Engl Ed). 2022 Sep-Oct;41(5):319-321. doi: 10.1016/j.remnie.2022.05.009. Epub 2022 May 28.

Authors

A Cardozo-Saavedra¹, S Ortiz², F J Alvarez Moro², P Bassa², E Carrillo-Villamizar², J R Garcia Garzón²

Affiliations

¹ CETIR, Grupo Biomédico ASCIRES, Esplugues de Llobregat, Barcelona, Spain. Electronic address: andersoncardozomd@gmail.com.
² CETIR, Grupo Biomédico ASCIRES, Esplugues de Llobregat, Barcelona, Spain.

PMID: 35637148
DOI: 10.1016/j.remnie.2022.05.009

No abstract available

MeSH terms

Fluorodeoxyglucose F18*
Humans
Positron Emission Tomography Computed Tomography
Positron-Emission Tomography
Radiopharmaceuticals
Tuberculosis, Spinal*

Substances

Radiopharmaceuticals
Fluorodeoxyglucose F18